{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:04:35Z","timestamp":1790395475684,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,10,11]],"date-time":"2009-10-11T00:00:00Z","timestamp":1255219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1750-1172-4-21","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T02:14:28Z","timestamp":1255400068000},"source":"Crossref","is-referenced-by-count":48,"title":["Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring"],"prefix":"10.1186","volume":"4","author":[{"given":"Bj\u00f6rn","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,11]]},"reference":[{"key":"155_CR1","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO: Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. 2001, 285: 2743-2749. 10.1001\/jama.285.21.2743.","journal-title":"JAMA"},{"key":"155_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ: Safety and efficacy of recombinant human alpha-galactosidase A--replacement therapy in Fabry's disease. N Engl J Med. 2001, 345: 9-16. 10.1056\/NEJM200107053450102.","journal-title":"N Engl J Med"},{"key":"155_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L: Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med. 1967, 276: 1163-1167.","journal-title":"N Engl J Med"},{"key":"155_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH: Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001, 38: 750-760. 10.1136\/jmg.38.11.750.","journal-title":"J Med Genet"},{"key":"155_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH: Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001, 38: 769-775. 10.1136\/jmg.38.11.769.","journal-title":"J Med Genet"},{"key":"155_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00428-008-0653-2","volume":"453","author":"C Valbuena","year":"2008","unstructured":"Valbuena C, Carvalho E, Bustorff M, Ganhao M, Relvas S, Nogueira R, Carneiro F, Oliveira JP: Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch. 2008, 453: 329-338. 10.1007\/s00428-008-0653-2.","journal-title":"Virchows Arch"},{"key":"155_CR7","first-page":"271","volume":"17","author":"R Safyan","year":"2006","unstructured":"Safyan R, Whybra C, Beck M, Elstein D, Altarescu G: An association study of inflammatory cytokine gene polymorphisms in Fabry disease. Eur Cytokine Netw. 2006, 17: 271-275.","journal-title":"Eur Cytokine Netw"},{"key":"155_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/ki.2008.576","volume":"75","author":"T Thomaidis","year":"2009","unstructured":"Thomaidis T, Relle M, Golbas M, Brochhausen C, Galle PR, Beck M, Schwarting A: Downregulation of alpha-galactosidase A upregulates CD77: functional impact for Fabry nephropathy. Kidney Int. 2009, 75: 399-407. 10.1038\/ki.2008.576.","journal-title":"Kidney Int"},{"key":"155_CR9","first-page":"5314","volume":"53","author":"M Mangeney","year":"1993","unstructured":"Mangeney M, Lingwood CA, Taga S, Caillou B, Tursz T, Wiels J: Apoptosis induced in Burkitt's lymphoma cells via Gb3\/CD77, a glycolipid antigen. Cancer Res. 1993, 53: 5314-5319.","journal-title":"Cancer Res"},{"key":"155_CR10","volume-title":"J Inherit Metab Dis","author":"P Rozenfeld","year":"2009","unstructured":"Rozenfeld P, Agriello E, De Francesco N, Martinez P, Fossati C: Leukocyte perturbation associated with Fabry disease. J Inherit Metab Dis. 2009,"},{"key":"155_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10545-007-0716-6","volume":"31","author":"G Altarescu","year":"2008","unstructured":"Altarescu G, Chicco G, Whybra C, Delgado-Sanchez S, Sharon N, Beck M, Elstein D: Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease. J Inherit Metab Dis. 2008, 31: 117-123. 10.1007\/s10545-007-0716-6.","journal-title":"J Inherit Metab Dis"},{"key":"155_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1651-2227.2008.00654.x","volume":"97","author":"DF Moore","year":"2008","unstructured":"Moore DF, Goldin E, Gelderman MP, Robinson C, Baer J, Ries M, Elkahloun A, Brady RO, Schiffmann R: Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry disease. Acta Paediatr Suppl. 2008, 97: 48-52. 10.1111\/j.1651-2227.2008.00654.x.","journal-title":"Acta Paediatr Suppl"},{"key":"155_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","volume":"95","author":"JS Shen","year":"2008","unstructured":"Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, Kaneski CR: Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab. 2008, 95: 163-168. 10.1016\/j.ymgme.2008.06.016.","journal-title":"Mol Genet Metab"},{"key":"155_CR14","volume-title":"J Inherit Metab Dis","author":"I Rohard","year":"2008","unstructured":"Rohard I, Schaefer E, Kampmann C, Beck M, Gal A: Association between polymorphisms of endothelial nitric oxide synthase gene (NOS3) and left posterior wall thickness (LPWT) of the heart in Fabry disease. J Inherit Metab Dis. 2008,"},{"key":"155_CR15","volume-title":"J Inherit Metab Dis","author":"RY Wang","year":"2008","unstructured":"Wang RY, Abe JT, Cohen AH, Wilcox WR: Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage. J Inherit Metab Dis. 2008,"},{"key":"155_CR16","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","volume":"28","author":"A Linhart","year":"2007","unstructured":"Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, Elliott PM: Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J. 2007, 28: 1228-1235. 10.1093\/eurheartj\/ehm153.","journal-title":"Eur Heart J"},{"issue":"1","key":"155_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijcard.2008.04.075","volume":"132","author":"R Toro","year":"2009","unstructured":"Toro R, Perez-Isla L, Doxastaquis G, Barba MA, Rivera GA, Pintos G, Barbados FJ, Mangas A, Zamorano JL: Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy. Int J Cardiol. 2009, 132 (1): 38-44. 10.1016\/j.ijcard.2008.04.075.","journal-title":"Int J Cardiol"},{"key":"155_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1651-2227.2008.00700.x","volume":"97","author":"C Kampmann","year":"2008","unstructured":"Kampmann C, Wiethoff CM, Whybra C, Baehner FA, Mengel E, Beck M: Cardiac manifestations of Anderson-Fabry disease in children and adolescents. Acta Paediatr. 2008, 97: 463-469. 10.1111\/j.1651-2227.2008.00700.x.","journal-title":"Acta Paediatr"},{"key":"155_CR19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.echo.2008.09.002","volume":"21","author":"T Palecek","year":"2008","unstructured":"Palecek T, Dostalova G, Kuchynka P, Karetova D, Bultas J, Elleder M, Linhart A: Right ventricular involvement in Fabry disease. J Am Soc Echocardiogr. 2008, 21: 1265-1268. 10.1016\/j.echo.2008.09.002.","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"155_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ultrasmedbio.2008.10.010","volume":"35","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, Strotmann JM, Niemann M, Herrmann S, Wilke M, Beer M, Voelker W, Ertl G, Emmert A, Wanner C, Breunig F: Heart Valve Involvement in Fabry Cardiomyopathy. Ultrasound Med Biol. 2009, 35 (5): 730-5. 10.1016\/j.ultrasmedbio.2008.10.010.","journal-title":"Ultrasound Med Biol"},{"key":"155_CR21","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2353\/ajpath.2008.070576","volume":"172","author":"C Chimenti","year":"2008","unstructured":"Chimenti C, Hamdani N, Boontje NM, DeCobelli F, Esposito A, Bronzwaer JG, Stienen GJ, Russo MA, Paulus WJ, Frustaci A, van d V: Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease. Am J Pathol. 2008, 172: 1482-1490. 10.2353\/ajpath.2008.070576.","journal-title":"Am J Pathol"},{"key":"155_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10545-008-0794-0","volume":"31","author":"T Kovarnik","year":"2008","unstructured":"Kovarnik T, Mintz GS, Karetova D, Horak J, Bultas J, Skulec R, Skalicka H, Aschermann M, Elleder M, Linhart A: Intravascular ultrasound assessment of coronary artery involvement in Fabry disease. J Inherit Metab Dis. 2008, 31: 753-760. 10.1007\/s10545-008-0794-0.","journal-title":"J Inherit Metab Dis"},{"key":"155_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/hrt.2006.104026","volume":"94","author":"DA Hughes","year":"2008","unstructured":"Hughes DA, Elliott PM, Shah J, Zuckerman J, Coghlan G, Brookes J, Mehta AB: Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart. 2008, 94: 153-158. 10.1136\/hrt.2006.104026.","journal-title":"Heart"},{"key":"155_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1399-0004.2004.00284.x","volume":"66","author":"L Spinelli","year":"2004","unstructured":"Spinelli L, Pisani A, Sabbatini M, Petretta M, Andreucci MV, Procaccini D, Lo SN, Federico S, Cianciaruso B: Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease. Clin Genet. 2004, 66: 158-165. 10.1111\/j.1399-0004.2004.00284.x.","journal-title":"Clin Genet"},{"key":"155_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s10545-008-0848-3","volume":"31","author":"JW Koskenvuo","year":"2008","unstructured":"Koskenvuo JW, Hartiala JJ, Nuutila P, Kalliokoski R, Viikari JS, Engblom E, Penttinen M, Knuuti J, Mononen I, Kantola IM: Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters. J Inherit Metab Dis. 2008, 31: 432-441. 10.1007\/s10545-008-0848-3.","journal-title":"J Inherit Metab Dis"},{"key":"155_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/ejechocard\/jen129","volume":"9","author":"T Kovacevic-Preradovic","year":"2008","unstructured":"Kovacevic-Preradovic T, Zuber M, Jost CH, Widmer U, Seifert B, Schulthess G, Fischer A, Jenni R: Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy. Eur J Echocardiogr. 2008, 9: 729-735. 10.1093\/ejechocard\/jen129.","journal-title":"Eur J Echocardiogr"},{"key":"155_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijcard.2008.03.007","volume":"130","author":"C Kampmann","year":"2008","unstructured":"Kampmann C, Linhart A, Baehner F, Palecek T, Wiethoff CM, Miebach E, Whybra C, Gal A, Bultas J, Beck M: Onset and progression of the Anderson-Fabry disease related cardiomyopathy. Int J Cardiol. 2008, 130: 367-373. 10.1016\/j.ijcard.2008.03.007.","journal-title":"Int J Cardiol"},{"key":"155_CR28","first-page":"49","volume-title":"Proceedings of the 8th International Symposium on Lysosomal Storage Disorders","author":"A Holmes","year":"2008","unstructured":"Holmes A, Reed MC, Baker RJ, Jeevaratnam P, Mehta AB, Hughes DA: Left ventricular posterior wall thickness in Anderson-Fabry Disease: Response to Enzyme Replacement Therapy and effect on MSSI. Proceedings of the 8th International Symposium on Lysosomal Storage Disorders. 2008, 49-Abstract A 18"},{"key":"155_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1445-5994.2008.01669.x","volume":"38","author":"T Lobo","year":"2008","unstructured":"Lobo T, Morgan J, Bjorksten A, Nicholls K, Grigg L, Centra E, Becker G: Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement. Intern Med J. 2008, 38: 407-414. 10.1111\/j.1445-5994.2008.01669.x.","journal-title":"Intern Med J"},{"key":"155_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/AJP.0b013e318074c986","volume":"23","author":"B Hoffmann","year":"2007","unstructured":"Hoffmann B, Beck M, Sunder-Plassmann G, Borsini W, Ricci R, Mehta A: Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey. Clin J Pain. 2007, 23: 535-542. 10.1097\/AJP.0b013e318074c986.","journal-title":"Clin J Pain"},{"key":"155_CR31","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1526-4637.2008.00470.x","volume":"9","author":"R Maag","year":"2008","unstructured":"Maag R, Binder A, Maier C, Scherens A, Toelle T, Treede RD, Baron R: Detection of a characteristic painful neuropathy in Fabry disease: a pilot study. Pain Med. 2008, 9: 1217-1223. 10.1111\/j.1526-4637.2008.00470.x.","journal-title":"Pain Med"},{"issue":"11","key":"155_CR32","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1136\/jnnp.2008.143693","volume":"79","author":"S Buechner","year":"2008","unstructured":"Buechner S, Moretti M, Burlina AP, Cei G, Manara R, Ricci R, Mignani R, Parini R, Di Vito R, Giordano GP, Simonelli P, Siciliano G, Borsini W: Central nervous system involvement in anderson-fabry diease: A clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry. 2008, 79 (11): 1249-54. 10.1136\/jnnp.2008.143693.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"155_CR33","first-page":"40","volume-title":"Proceedings of the 8th International Symposium on Lysosomal Storage Disorders","author":"F Alari","year":"2008","unstructured":"Alari F, Buechner S, Borsini W, Marinoni M: Decrease of cerebral blood flow velocity during enzyme replacement therapy in Anderson-Fabry disease: A transcranial Doppler ultrasonography study. Proceedings of the 8th International Symposium on Lysosomal Storage Disorders. 2008, 40-Abstract A9"},{"key":"155_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/jmri.20162","volume":"20","author":"DF Moore","year":"2004","unstructured":"Moore DF, Ye F, Brennan ML, Gupta S, Barshop BA, Steiner RD, Rhead WJ, Brady RO, Hazen SL, Schiffmann R: Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: An arterial spin tagging study. J Magn Reson Imaging. 2004, 20: 674-10.1002\/jmri.20162.","journal-title":"J Magn Reson Imaging"},{"key":"155_CR35","volume-title":"Proceedings of the 5th Symposium on Lysosomal Storage Disorders","author":"I Schermuly","year":"2008","unstructured":"Schermuly I, M\u00fcller MJ, Keller I, Marin D, Albrecht J, Beck M, Stoeter P, Fellgiebel A: Neuropsychiatric symptoms, disease burden and brain structure in Fabry disease. Proceedings of the 5th Symposium on Lysosomal Storage Disorders. 2008, Abstract P31, P42"},{"key":"155_CR36","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10545-007-0708-6","volume":"30","author":"AL Cole","year":"2007","unstructured":"Cole AL, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH: Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis. 2007, 30: 943-951. 10.1007\/s10545-007-0708-6.","journal-title":"J Inherit Metab Dis"},{"key":"155_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","volume":"51","author":"C Tondel","year":"2008","unstructured":"Tondel C, Bostad L, Hirth A, Svarstad E: Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am J Kidney Dis. 2008, 51: 767-776. 10.1053\/j.ajkd.2007.12.032.","journal-title":"Am J Kidney Dis"},{"key":"155_CR38","first-page":"245","volume-title":"Contrib Nephrol","author":"C Whybra","year":"2001","unstructured":"Whybra C, Wendrich K, Ries M, Gal A, Beck M: Clinical manifestation in female Fabry disease patients. Contrib Nephrol. 2001, 245-250. full_text."},{"key":"155_CR39","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/ndt\/gfm848","volume":"23","author":"A Ortiz","year":"2008","unstructured":"Ortiz A, Oliveira JP, Waldek S, Warnock DG, Cianciaruso B, Wanner C: Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy. Nephrol Dial Transplant. 2008, 23: 1600-1607. 10.1093\/ndt\/gfm848.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"155_CR40","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/jmg.2005.036327","volume":"43","author":"P Deegan","year":"2006","unstructured":"Deegan P, Baehner AF, Barba-Romero MA, Hughes D, Kampmann C, Beck M: Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet. 2006, 43 (4): 347-352. 10.1136\/jmg.2005.036327.","journal-title":"J Med Genet"},{"key":"155_CR41","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10545-008-0900-3","volume":"31","author":"P Vylet'al","year":"2008","unstructured":"Vylet'al P, Hulkova H, Zivna M, Berna L, Novak P, Elleder M, Kmoch S: Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy. J Inherit Metab Dis. 2008, 31: 508-517. 10.1007\/s10545-008-0900-3.","journal-title":"J Inherit Metab Dis"},{"key":"155_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000168482","volume":"29","author":"S Feriozzi","year":"2008","unstructured":"Feriozzi S, Schwarting A, Sunder-Plassmann G, West M, Cybulla M: Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease. Am J Nephrol. 2008, 29: 353-361. 10.1159\/000168482.","journal-title":"Am J Nephrol"},{"issue":"5","key":"155_CR43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","volume":"64","author":"RJ Hopkin","year":"2008","unstructured":"Hopkin RJ, Bissler J, Banikazemi M, Clarke L, Eng CM, Germain DP, Lemay R, Tylki-Szymanska A, Wilcox WR: Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry. Pediatr Res. 2008, 64 (5): 550-555. 10.1203\/PDR.0b013e318183f132.","journal-title":"Pediatr Res"},{"key":"155_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U, Dehout F, Garcia DL, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M: Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004, 34: 236-242. 10.1111\/j.1365-2362.2004.01309.x.","journal-title":"Eur J Clin Invest"},{"key":"155_CR45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","volume":"30","author":"CM Eng","year":"2007","unstructured":"Eng CM, Fletcher J, Wilcox WR, Waldek S, Scott CR, Sillence DO, Breunig F, Charrow J, Germain DP, Nicholls K, Banikazemi M: Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis. 2007, 30: 184-192. 10.1007\/s10545-007-0521-2.","journal-title":"J Inherit Metab Dis"},{"key":"155_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, Ponzone A, Desnick RJ: High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet. 2006, 79: 31-40. 10.1086\/504601.","journal-title":"Am J Hum Genet"},{"issue":"Suppl B","key":"155_CR47","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0149-2918(08)80035-5","volume":"30","author":"OA Bodamer","year":"2008","unstructured":"Bodamer OA: Newborn screening in Fabry disease: what can be achieved with early diagnosis?. Clin Ther. 2008, 30 (Suppl B): S41-10.1016\/S0149-2918(08)80035-5.","journal-title":"Clin Ther"},{"key":"155_CR48","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jacc.2008.02.050","volume":"51","author":"GE Linthorst","year":"2008","unstructured":"Linthorst GE, Poorthuis BJ, Hollak CE: Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results. J Am Coll Cardiol. 2008, 51: 2082-2083. 10.1016\/j.jacc.2008.02.050.","journal-title":"J Am Coll Cardiol"},{"key":"155_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF: Prevalence of lysosomal storage disorders. JAMA. 1999, 281: 249-254. 10.1001\/jama.281.3.249.","journal-title":"JAMA"},{"issue":"3","key":"155_CR50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1432-2277.2008.00791.x","volume":"22","author":"J Kleinert","year":"2009","unstructured":"Kleinert J, Kotanko P, Spada M, Pagliardini S, Paschke E, Paul K, Voigtlander T, Wallner M, Kramar R, Stummvoll HK, Schwarz C, Horn S, Holzer H, Fodinger M, Sunder-Plassmann G: Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria. Transpl Int. 2009, 22 (3): 287-292. 10.1111\/j.1432-2277.2008.00791.x.","journal-title":"Transpl Int"},{"issue":"Suppl 7","key":"155_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ndt\/11.supp7.4","volume":"11","author":"D Tsakiris","year":"1996","unstructured":"Tsakiris D, Simpson HK, Jones EH, Briggs JD, Elinder CG, Mendel S, Piccoli G, dos Santos JP, Tognoni G, Vanrenterghem Y, Valderrabano F: Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrol Dial Transplant. 1996, 11 (Suppl 7): 4-20.","journal-title":"Nephrol Dial Transplant"},{"key":"155_CR52","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1523-1755.2002.00097.x","volume":"61","author":"R Thadhani","year":"2002","unstructured":"Thadhani R, Wolf M, West ML, Tonelli M, Ruthazer R, Pastores GM, Obrador GT: Patients with Fabry disease on dialysis in the United States. Kidney Int. 2002, 61: 249-255. 10.1046\/j.1523-1755.2002.00097.x.","journal-title":"Kidney Int"},{"key":"155_CR53","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, Kanzaki T, Enriquez AL, Eng CM, Tanaka H, Tei C, Desnick RJ: Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \"renal variant\" phenotype. Kidney Int. 2003, 64: 801-807. 10.1046\/j.1523-1755.2003.00160.x.","journal-title":"Kidney Int"},{"key":"155_CR54","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/08860220802353777","volume":"30","author":"DB Porsch","year":"2008","unstructured":"Porsch DB, Nunes AC, Milani V, Rossato LB, Mattos CB, Tsao M, Netto C, Burin M, Pereira F, Matte U, Giugliani R, Barros EJ: Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report. Ren Fail. 2008, 30: 825-830. 10.1080\/08860220802353777.","journal-title":"Ren Fail"},{"key":"155_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00428-008-0586-9","volume":"452","author":"J Keslova-Veselikova","year":"2008","unstructured":"Keslova-Veselikova J, Hulkova H, Dobrovolny R, Asfaw B, Poupetova H, Berna L, Sikora J, Golan L, Ledvinova J, Elleder M: Replacement of alpha-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients. Virchows Arch. 2008, 452: 651-665. 10.1007\/s00428-008-0586-9.","journal-title":"Virchows Arch"},{"key":"155_CR56","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1177\/0091270007305299","volume":"47","author":"M Ries","year":"2007","unstructured":"Ries M, Clarke JT, Whybra C, Mehta A, Loveday KS, Brady RO, Beck M, Schiffmann R: Enzyme replacement in Fabry disease: pharmacokinetics and pharmacodynamics of agalsidase alpha in children and adolescents. J Clin Pharmacol. 2007, 47: 1222-1230. 10.1177\/0091270007305299.","journal-title":"J Clin Pharmacol"},{"key":"155_CR57","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jpeds.2007.09.007","volume":"152","author":"JE Wraith","year":"2008","unstructured":"Wraith JE, Tylki-Szymanska A, Guffon N, Lien YH, Tsimaratos M, Vellodi A, Germain DP: Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease. J Pediatr. 2008, 152: 563-70. 10.1016\/j.jpeds.2007.09.007. 570","journal-title":"J Pediatr"},{"key":"155_CR58","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ymgme.2008.03.003","volume":"94","author":"AC Vedder","year":"2008","unstructured":"Vedder AC, Breunig F, Donker-Koopman WE, Mills K, Young E, Winchester B, Ten Berge IJ, Groener JE, Aerts JM, Wanner C, Hollak CE: Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3. Mol Genet Metab. 2008, 94: 319-325. 10.1016\/j.ymgme.2008.03.003.","journal-title":"Mol Genet Metab"},{"key":"155_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1086\/422366","volume":"75","author":"WR Wilcox","year":"2004","unstructured":"Wilcox WR, Banikazemi M, Guffon N, Waldek S, Lee P, Linthorst GE, Desnick RJ, Germain DP: Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. Am J Hum Genet. 2004, 75: 65-74. 10.1086\/422366.","journal-title":"Am J Hum Genet"},{"key":"155_CR60","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/glycob\/cwg034","volume":"13","author":"K Lee","year":"2003","unstructured":"Lee K, Jin X, Zhang K, Copertino L, Andrews L, Baker-Malcolm J, Geagan L, Qiu H, Seiger K, Barngrover D, McPherson JM, Edmunds T: A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease. Glycobiology. 2003, 13: 305-313. 10.1093\/glycob\/cwg034.","journal-title":"Glycobiology"},{"key":"155_CR61","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/FPC.0b013e32830500f4","volume":"18","author":"SH Shin","year":"2008","unstructured":"Shin SH, Kluepfel-Stahl S, Cooney AM, Kaneski CR, Quirk JM, Schiffmann R, Brady RO, Murray GJ: Prediction of response of mutated alpha-galactosidase A to a pharmacological chaperone. Pharmacogenet Genomics. 2008, 18: 773-780. 10.1097\/FPC.0b013e32830500f4.","journal-title":"Pharmacogenet Genomics"},{"key":"155_CR62","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JM Aerts","year":"2008","unstructured":"Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE, Vedder AC, Rombach SM, Cox-Brinkman J, Somerharju P, Boot RG, Hollak CE, Brady RO, Poorthuis BJ: Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA. 2008, 105: 2812-2817. 10.1073\/pnas.0712309105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR63","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1399-0004.2008.01012.x","volume":"74","author":"R Parini","year":"2008","unstructured":"Parini R, Rigoldi M, Santus F, Furlan F, De Lorenzo P, Valsecchi G, Concolino D, Strisciuglio P, Feriozzi S, Di Vito R, Ravaglia R, Ricci R, Morrone A: Enzyme replacement therapy with agalsidase alfa in a cohort of Italian patients with Anderson-Fabry disease: testing the effects with the Mainz Severity Score Index. Clin Genet. 2008, 74: 260-266. 10.1111\/j.1399-0004.2008.01012.x.","journal-title":"Clin Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-4-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-1172-4-21\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-4-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T21:21:08Z","timestamp":1548192068000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-4-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,11]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-4-21","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,11]]},"article-number":"21"}}